[HTML][HTML] The 2022 World Health Organization classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours
The fifth edition of the World Health Organization (WHO) classification of urogenital tumours
(WHO “Blue Book”), published in 2022, contains significant revisions. This review …
(WHO “Blue Book”), published in 2022, contains significant revisions. This review …
[HTML][HTML] What's new in the WHO 2022 classification of kidney tumours?
R Alaghehbandan, F Siadat, K Trpkov - Pathologica, 2023 - ncbi.nlm.nih.gov
Summary The World Health Organization (WHO) 2022 classification of urinary and male
genital tumours (5th edition) has significantly improved our understanding of the …
genital tumours (5th edition) has significantly improved our understanding of the …
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases
A distinct renal tumor has recently been described as “high-grade oncocytic renal tumor”
and “sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm”. The …
and “sporadic renal cell carcinoma with eosinophilic and vacuolated cytoplasm”. The …
TSC/MTOR-associated eosinophilic renal tumors exhibit a heterogeneous clinicopathologic spectrum: a targeted next-generation sequencing and gene expression …
Q **a, X Wang, M Zhao, H He, R Fang… - The American Journal …, 2022 - journals.lww.com
Background: Several TSC1/2-or MTOR-mutated eosinophilic renal tumor subsets are
emerging, including eosinophilic solid and cystic renal cell carcinoma (ESC RCC) …
emerging, including eosinophilic solid and cystic renal cell carcinoma (ESC RCC) …
Low‐grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity
Low‐grade oncocytic tumour (LOT) of the kidney has recently emerged as a potential novel
tumour type. Despite similarity to oncocytoma or eosinophilic chromophobe renal cell …
tumour type. Despite similarity to oncocytoma or eosinophilic chromophobe renal cell …
[HTML][HTML] Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney
Low-grade oncocytic tumor (LOT) of the kidney is a recently described entity with poorly
understood pathogenesis. Using next-generation sequencing (NGS) and complementary …
understood pathogenesis. Using next-generation sequencing (NGS) and complementary …
Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): incidence in a single institutional experience with clinicopathological and molecular …
Low-grade oncocytic tumor of the kidney (LOT) is characterized by cytoplasmic eosinophilia
and a CK7-positive/CD117-negative immunophenotype. Morphologically, they exhibit …
and a CK7-positive/CD117-negative immunophenotype. Morphologically, they exhibit …
[HTML][HTML] Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1
A Morini, T Drossart, MO Timsit, M Sibony, V Vasiliu… - Modern Pathology, 2022 - Elsevier
Low-grade oncocytic renal tumor (LOT) is an emerging provisional entity, described as rare
solid renal oncocytic/eosinophilic tumor sharing diffuse CK7 and negative CD117 …
solid renal oncocytic/eosinophilic tumor sharing diffuse CK7 and negative CD117 …
A pilot radiometabolomics integration study for the characterization of renal oncocytic neoplasia
Differentiating benign renal oncocytic tumors and malignant renal cell carcinoma (RCC) on
imaging and histopathology is a critical problem that presents an everyday clinical …
imaging and histopathology is a critical problem that presents an everyday clinical …
Recent advances in renal tumors with TSC/mTOR pathway abnormalities in patients with tuberous sclerosis complex and in the sporadic setting
Simple Summary In the past decade, several novel renal neoplasms characterized by
mutations in the tuberous sclerosis complex (TSC) or mechanistic target of rapamycin …
mutations in the tuberous sclerosis complex (TSC) or mechanistic target of rapamycin …